GI CANCERS

Latest News

FDA Fast Tracks IMM-1-104 for PDAC Treatment
FDA Fast Tracks IMM-1-104 for PDAC Treatment

February 21st 2024

IMM-1-104 has gained a fast track designation from the FDA for the treatment of patients with pancreatic ductal adenocarcinoma who have progressed after 1 line of treatment.

First Patient Treated With AgenT-797 in Phase 2 Trial for GI Cancers
First Patient Treated With AgenT-797 in Phase 2 Trial for GI Cancers

February 14th 2024

FDA Approves First-Line NALIRIFOX for Metastatic PDAC
FDA Approves First-Line NALIRIFOX for Metastatic PDAC

February 13th 2024

FDA Grants Breakthrough Therapy Designation to Novel Agent in GEP-NETs
FDA Grants Breakthrough Therapy Designation to Novel Agent in GEP-NETs

February 12th 2024

Roundtable Roundup: February | Biliary Tract Cancer
Roundtable Roundup: February | Biliary Tract Cancer

February 12th 2024

Video Series
Video Interviews
Podcasts

More News